GlassScriptPhysician profile
Andrew Joseph Smith
NPI 1033606058
$4,786.30
in general payments reported to CMS, 2019-2025
25 companies · $840 in 2025
The $840 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $395 · 2022: $651 · 2023: $365 · 2024: $2,536 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,890 · Food and Beverage: $1,771 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,889.59 |
| Food and Beverage | $1,771.36 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,926.42 | 2024 | Everest Spinal System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $473.65 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $361.55 | 2021-2025 | Farxiga, Brilinta, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $285.18 | 2022-2025 | Camzyos, Eliquis |
| Abiomed | $183.62 | 2024-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $175.72 | 2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.97 | 2021-2025 | Lifevest |
| Medtronic, INC. | $172.19 | 2023-2025 | Pulseselect, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Merck Sharp & Dohme LLC | $150.24 | 2022-2025 | Verquvo |
| Irhythm Technologies, INC. | $140.23 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Inari Medical, INC. | $121.42 | 2022 | |
| Boston Scientific Corporation | $94.94 | 2022-2023 | |
| Pfizer INC. | $82.59 | 2021-2025 | |
| Novo Nordisk INC | $66.96 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $65.39 | 2025 | Assure Wcd |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $60.08 | 2024 | Xarelto |
| Axsome Therapeutics, INC. | $40.67 | 2022-2023 | Auvelity |
| Amgen INC. | $38.61 | 2022-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $34.14 | 2024 | |
| Livanova USA, INC. | $27.80 | 2022 | |
| Scpharmaceuticals INC. | $27.70 | 2024 | |
| Cardiva Medical, INC. | $24.76 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $19.82 | 2025 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $19.38 | 2025 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $19.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.